The most important financial indicators for the company Depomed Eximpharm Srl - Unique Identification Number 26573672:
sales in 2023 was
301.243
euro, registering a net profit of
-1.810
euro and having an average number of
3
employees.
Firma isi desfasoara activitatea in domeniul Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales decreased by -13.5%, from 349.382 euro in the year 2022, to 301.243 euro in 2023.
The Net Profit decreased by -29.842 euro, from 29.933 euro in 2022, to 0 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
176.152 euro in 2023 which includes Inventories of
46.398 euro, Receivables of
36.921 euro and cash availability of
92.833 euro.
The company's Equity was valued at
61.367 euro, while total Liabilities amounted to
128.193 euro.
Equity decreased by -30.763 euro, from 92.411 euro in 2022, to 61.367 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Depomed Eximpharm Srl